Basic Information

AUSTIN, TX, 78759-5673


Company Profile

TeVido’s proprietary platform technology uses 3D bio-printing and a patient’s own living cells to build custom grafts that address significant unmet needs in the broad field of reconstructive and cosmetic surgery - where current fillers, fat injections and skin/tissue grafting results are unpredictable. The first product will improve nipple reconstruction, for breast cancer survivors, where current procedures flatten and fade over time. The technology has out-licensing potential in the field of tissue engineering and bioprinting.

Additional Details

Field Value
DUNS: 967853248
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 7

  1. SBIR Phase II: Bioprinted fat grafts for improved nipple reconstruction after breast cancer

    Amount: $750,000.00

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is the delivery of a custom-made nipple made from a patient's own cells for women who ha ...

    SBIR Phase II 2014 National Science Foundation
  2. Using 3d bioprinting for Nipple Areola Complex (NAC) reconstruction

    Amount: $150,000.00

    TeVido Project Summary/Abstract Globally, in 2010, there were slightly more than 1 million incidences of breast cancer. In the US ~200,000 women are diagnosed with breast cancer annually and nearly 40 ...

    SBIR Phase I 2014 Department of Health and Human Services
  3. SBIR Phase I: Bioprinted Prevascularized Adipose Graft for Soft Tissue Voids

    Amount: $150,000.00

    This Small Business Innovation Research Phase I project proposes a new tissue engineered vascularized adipose graft product for reconstructive surgery. Of the approximately one million new breast canc ...

    SBIR Phase I 2013 National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government